Benlysta 200 MG/ML autoinjectml
Ended Awarded Last action
- Contract number
- SPE2DR26F1AY3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,947
Award facts
- Contract value 100% obligated
- $13,946.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,946.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Benlysta 200 mg/mL auto-injector units. This is a non-set-aside, competitively awarded contract with a completion date of February 20, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical and medical supplies to support military healthcare programs globally.
Benlysta (belimumab) is a monoclonal antibody used to treat systemic lupus erythematosus and lupus nephritis, making this delivery order part of the broader pharmaceutical supply chain supporting Department of Defense medical treatment facilities and military healthcare beneficiaries. As a major pharmaceutical distributor, AmerisourceBergen regularly fulfills federal medical procurement needs through the DLA Medical Supply Chain, delivering a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F1AY3?
SPE2DR26F1AY3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F1AY3 worth?
The government has obligated $13,947 on SPE2DR26F1AY3.
Is contract SPE2DR26F1AY3 an order under another contract?
Yes. SPE2DR26F1AY3 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AY3 competed?
The extent of competition for SPE2DR26F1AY3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award